Akerele JO, Okhamafe AO. Influence of oral co-administered metallic drugs on
ofloxacin pharmacokinetics. J Antimicrob Chemother. 1991;28:87-94.
Balfour JA, Wiseman LR. Moxifloxacin. Drugs. 1999;57(3):363-374.
Brouwers J. Drug interactions with quinolone antibacterials. Drug
Safety. 1992;7(4):268-281.
Campbell NR, Hasinoff BB. Iron supplements: a common cause of drug
interactions. Br J Clin Pharmacol. 1991;31(3):251-255.
Campbell NR, Hasinoff BB, Meddings JB, Anderson WD, Robertson S, Granberg K.
Ferrous sulfate reduces cimetidine absorption. Dig Dis Sci.
1993;38(5):950-954.
Hines Burnham T, et al, eds. Drug Facts and Comparisons. St. Louis,
MO:Facts and Comparisons;2000:1294.
Kara M, Hasinoff BB, McKay DW, et al. Clinical and chemical interactions
between iron preparations and ciprofloxacin. Br J Clin Pharmacol.
1991;31(3):257-261.
Leonard JP, Desager JP, Beckers C, Harvengt C. In vitro binding of various
biological substances by two hypocholesterolaemic resins. Cholestyramine and
colestipol. Arzneim Forsch/Drug Res. 1979;29:979-981.
Li RC, Lo KN, Lam JS, et al. Effects of order of magnesium exposure on the
postantibiotic effect and bactericidal activity of ciprofloxacin. J
Chemother. 1999;11(4):243-247.
Neuvonen PJ. Interactions with the absorption of tetracyclines. Drugs.
1976;11(1):45-54.
Okhamafe AO, Akerele JO, Chukuka CS. Pharmacokinetic interactions of
norfloxacin with some metallic agents. Int J Pharmaceutics.
1991;68:11-16.
Physicians' Desk Reference, 54th ed. Montvale, NJ: Medical
Economics Company; 2000.
Polk RE. Drug-drug interactions with ciprofloxacin and other
fluoroquinolones. Am J Med. 1989;87(Suppl5A):76-81.
Schaefer JP, Tam Y, Hasinoff BB, et al. Ferrous sulphate interacts with
captopril. Br J Clin Pharmacol. 1998;46(4):377-381.
Shakir KM, Chute JP, Aprill BS, Lazarus AA. Ferrous sulfate-induced increase
in requirement for thyroxine in a patient with primary hypothyroidism. South
Med J. 1997;90(6):637-639.
Tyrer LB. Nutrition and the pill. J Reprod Med. 1984;29(7
Suppl):547-550.